PM360

SEPTEMBER 21, 2023

Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.

Management 105

Management Manufacturing Sales Competition 105

PM360

MAY 15, 2023

After a developmental day of shadowing a pharma sales rep, the fire was lite and she joined the sales team never looking back, ultimately landing her a role at ConnectiveRx in 2010. Laura is not shy about sharing her cancer experience. Laura has educated the new ConnectiveRx employees on the “real” patient journey.

Sales 94

Sales Pharma sales reps Prescription Recruitment 94

PM360

DECEMBER 14, 2023

Survey any physician if they’ve been asked by a patient about a prescription weight loss medication and you’ll hear a resounding “yes.” The recent Sermo Barometer confirms that 89% of 300+ global practitioners have seen an increase in patients proactively requesting prescription weight loss medications.

Medical 105

Medical Side effects Physicians Prescription 105

PM360

OCTOBER 13, 2023

Doctor Docs: Targeting Trust Between Pharma and HCPs A new study shows the crucial link in pharma marketers’ digital engagement strategy with HCPs is in jeopardy—trust. and France regarding pharma-provided digital platforms. One participant summed up these perceptions by stating “It’s a pharmaceutical site, you know.

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. “The industry now regards the current approach, due to end in 2023, as broken.” VPAS tax on top. .” VPAS tax on top.

Pharma 70

Pharma Government Manufacturing Competition 70

Eversana Intouch

JANUARY 19, 2023

Success in 2023 will mean addressing each of those five issues meaningfully – understanding them fully and giving them real action, not just lip service. Pharma marketers in 2023 need to: Look for blind spots. Each year, we forecast several trends that will influence life-sciences marketing the most in the months to come ahead.

Medical 52

Medical Education Competition Marketing 52

Pharmaceutical Technology

JUNE 21, 2023

AGEPHA Pharma has received approval from the US Food and Drug Administration (FDA) for LODOCO (colchicine, 0.5 The company expects to launch LODOCO for prescription use in the second half of 2023. mg tablet) to treat cardiovascular disease.

Food and Drug Administration 98

Food and Drug Administration FDA Prescription Food 98

PM360

APRIL 7, 2023

This is especially significant for manufacturers of high-cost specialty drugs, who will now face a recurring additional 20% charge on virtually every prescription fill. pharma sales in 2020) and the size of 340B discounts (25-50%), companies may see significantly reduced revenues for important products. The 340B battle will rage on.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

World of DTC Marketing

MARCH 17, 2021

The rapid rollout of Covid-19 vaccines has made household names of Pfizer and AstraZeneca, and the whole industry is winning praise for co-operation” However, the bump in reputation will be short-lived because companies need to earn the public’s trust every day, and pharma is already damaging their perception with people.

Pharma 186

Pharma Competition Prescription Doctors 186

PM360

JULY 13, 2023

By fostering cross-stakeholder coordination and support across pharma brands, HCPs, pharmacies, and insurance companies, we can pave the way for better solutions that enhance adherence and, ultimately, improve patient outcomes. What if the industry were to incentivize persistence over new prescriptions?

Medical 98

Medical Patients Education Transportation 98

European Pharmaceutical Review

APRIL 21, 2023

6 Article: Five potential EU regulatory changes impacting the life sciences industry in 2023 … Scrutinising the supply chain An important but often opaque consideration is the supply chains in non-EU countries, which play a predominant role especially in the production of generic drugs and antibiotics. Baltruks D, Sowa M, Voss M.

Pharma 80

Pharma Food and Drug Administration Medicine Pharmaceutical 80

European Pharmaceutical Review

NOVEMBER 8, 2022

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. 1435 (“Affordable Prescriptions for Patients Act of 2021”), [link] gov/bill/117th-congress/senate-bill/1435/text; H.R. Actavis, 570 U.S. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

World of DTC Marketing

MAY 19, 2021

While AbbVie is a poster for everything wrong with pharma, what they have done doesn’t apply to ALL pharma companies. The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. ” Rep Katie Porter.

Pharma 181

Pharma Prescription Patients Safety 181

Eversana Intouch

FEBRUARY 23, 2023

Let’s talk about the current economic uncertainty and what it means for pharma marketers. We heard it from pharmaceutical executives, who see inflation as their top concern in 2023; from economists we interviewed; and most importantly, from patients, in a recent survey of 200 American patients that EVERSANA INTOUCH conducted.

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Let’s talk about the current economic uncertainty and what it means for pharma marketers. We heard it from pharmaceutical executives, who see inflation as their top concern in 2023; from economists we interviewed; and most importantly, from patients, in a recent survey of 200 American patients that EVERSANA INTOUCH conducted.

Marketing 52

Marketing Pharma Patients Insurance 52

pharmaphorum

NOVEMBER 16, 2022

Walmart has become the latest big pharmacy chain in the US to put forward a settlement to resolve claims it contributed to the national opioid crisis by failing to regulate prescriptions at its outlets. billion for Mallinckrodt , and $450 million for Endo Pharma. The retail giant has confirmed it has offered $3.1

Prescription 52

Prescription Government Retail Pharma 52

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Figure 1: Share of net spending for specialty and traditional prescription medications. Households in 2022,” May 2023. 7 Figure 3: Share of U.S.

Prescription 52

Prescription Medical Distribution Patients 52

World of DTC Marketing

MARCH 10, 2022

The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. The increase followed total Humira price hikes of 19 percent during 2017 and 2018. The executives at AbbVie make over $300 million.

Prescription 205

Prescription Pharmaceutical products Pharmaceutical Manufacturing 205

Contrarian Sales Techniques

FEBRUARY 24, 2023

For instance… I would like to share an idea with you that I believe has great potential for local pharma companies in the current business landscape. I believe that the telemedicine industry presents a significant opportunity for pharma companies to expand their business and contribute to improving healthcare services in the country.

Medical sales reps 52

Medical sales reps Medical sales Medical Sales 52

PM360

APRIL 7, 2023

With new “disruptive” market entrants, how does the PBM landscape change, how are consumer perceptions altered, and how do pharma marketers stay ahead of the game to deliver differentiated value for brands? This program, powered by GoodRx, bills itself as: “Free prescriptions, plus hundreds of prescriptions for $6 or less with membership.”

Marketing 52

Marketing Prescription Insurance Retail 52

Clarivate

APRIL 18, 2024

Amazon’s big splash happened in February 2023 when it purchased the national primary-care practice One Medical for $3.9 RxPass offers more than 50 select prescriptions at no additional cost for $5 per month. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.

Retail 52

Retail Healthcare Healthcare Physicians 52

PM360

JULY 13, 2023

If one of those conditions is type 2 diabetes, that person may be taking seven prescription medications, 1 managing two or more additional chronic conditions, 2 and paying $13,000 per year on healthcare. senior adults (aged 65+) 7 taking five or more prescription medications. 3 They are also 2.6 In the U.S., 5 This links to 22% of U.S.

Prescription 52

Prescription Medical Physicians Education 52

Pharma Leaders

MARCH 26, 2023

have introduced the Affordable Insulin Now Act of 2023, which would cap out-of-pocket insulin costs at $35 a month for both insured and uninsured individuals. Raphael Warnock (D-Ga.) and John Kennedy (R-La.) This bill is a follow-up to a bill Sen. The bill was signed into law in August 2022.

Insurance 52

Insurance Prescription 52

Pharmaceutical Technology

OCTOBER 31, 2022

The regulator has set 29 August 2023 as a Prescription Drug User Fee Act (PDUFA) goal date. The company has also established partnerships with Ajinomoto Bio-Pharma Services for finished drug products and with FUJIFILM Diosynth Biotechnologies for drug substance manufacturing.

Food and Drug Administration 59

Food and Drug Administration FDA Distribution Prescription 59

pharmaphorum

OCTOBER 24, 2022

A sweetened offer from Sumitomo Pharma has convinced endocrinology specialist Myovant to agree to a takeover, after its first was rejected. “Myovant’s two products…have substantial potential,” said Sumitomo Pharma’s chief executive Hiroshi Nomura. The stock hit just under $25 in trading today.

Biopharma 63

Biopharma Pharma Prescription Marketing 63

PM360

MAY 15, 2023

Because nearly all prescriptions are now written electronically. The Medical Literature Reports on POC Too; They Call it “Nudging” It’s not just pharma that’s interested in changing prescriber behavior. And to do that in today’s digital age, you’ve got to think “EHR.” An entire academic ecosystem is focused on physician “nudging.”

Marketing 52

Marketing Electronics Doctors Physicians 52

PM360

AUGUST 9, 2022

The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. Pharma Manufacturer Solutions. Vincent Keunen.

Prescription 105

Prescription Medical Side effects Patients 105

PM360

JULY 13, 2023

Launched in April 2023, BrightInsight’s PSP+ Companion App, built on the compliant BrightInsight Platform, connects patients to the resources they need to complete prior authorization, register for financial assistance, understand and track their therapies, and much more. But outdated manual processes are complex and leave many patients out.

Education 89

Education Medical Media Patients 89

pharmaphorum

AUGUST 31, 2022

The therapy has already been approved in the EU and UK as a medical device, and Futura is hoping to secure FDA approval of the formulation in the first quarter of 2023 as an over-the-counter (OTC) product. ” The post Futura eyes FDA filing as topical ED drug passes phase 3 test appeared first on.

FDA 52

FDA Side effects Prescription Medical 52

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. Humira, the long-running blockbuster autoimmune drug, was not eligible for negotiations since it will have nine biosimilars on the market by the end of 2023. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Eversana Intouch

MARCH 19, 2024

They are more likely than men to suffer chronic conditions and use prescription drugs across all age groups. Brands like Bodyform, Modybodi and many other pharma brands are leading women’s healthcare marketing to highlight the raw, authentic emotions that come with being a woman, but are rarely acknowledged.

Healthcare 59

Healthcare Healthcare Marketing Prescription 59

European Pharmaceutical Review

JANUARY 25, 2024

It emphasises its ability to make information interoperable with electronic health systems such as e-prescription and electronic health records. References European Commission, (26 April 2023). Euractiv (6 October 2023). European Commission (26 April 2023). Article 63 Euractiv (26 September 2023).

Healthcare 80

Healthcare Healthcare Electronics Safety 80

pharmaphorum

JANUARY 9, 2023

This Nine for 2023 three-part series will argue that, this year, the future-facing Janus prediction of unprecedented and transformative change is true. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.

Medicine 85

Medicine Healthcare Healthcare Pharma 85

PM360

DECEMBER 14, 2022

that didn’t stop us from asking 10 industry experts to take their best shot at anticipating what to expect in 2023 and beyond. So, in order to help best prepare you for what might come, we asked these 10 individuals to peer into their crystal balls and let us know: What will be the biggest trend(s) marketers will be talking about in 2023?

Marketing 91

Marketing Patients Healthcare Healthcare 91

Clarivate

JULY 5, 2023

biologics market and reduce prescription drug costs. When AMJETIVA finally launched at the end of January 2023, its unusual, tiered pricing strategy made headlines. from 91% in 2023 to 36% by 2031. By end of year, as many as ten adalimumab biosimilars could be on the U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn.

Marketing 97

Marketing Physicians Manufacturing Competition 97

pharmaphorum

AUGUST 17, 2022

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies that will defend themselves from the allegations.

Sales 52

Sales Prescription Manufacturing FDA 52

pharmaphorum

SEPTEMBER 30, 2022

The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma’s intravenous Radicava (edaravone) was cleared by the FDA in 2017. An oral version of edaravone was cleared this year. Bad news for Biohaven.

FDA 82

FDA Doctors Patients Prescription 82